Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Immunome IPO on target as investors bet big on gene, cell therapies
2 Immunome to become Philadelphia region's sixth life sciences IPO of 2020
3 Why I'm optimistic about Philly tech, and why you should be, too: Notes from a former investor
4 Guiding light: Main Line startup taps Lankenau Institute’s glow tech to make antibodies
5 Immunome to get up to $13.3M in government funding for potential Covid-19 drug
6 Novel antibody breaks bacterial biofilms and prevents sepsis in mice
7 New immunotherapeutic strategy shows promise in eradicating infectious biofilms
8 How to Buy the Immunome Stock IPO
9 Immunome Awarded Department of Defense Contract to Develop Biosynthetic Convalescent Plasma for COVID-19
10 Immunome Appoints Michael J. Morin, PhD, As President And Chief Scientific Officer
11 The List lines up BBC's David Low as CEO to meet increasing tech and data demands
12 2020-07-13 08:30:14.59 More Than $97.8 Million In Prizes Awarded In June
13 Supporters
14 Rhabdovirus-Based Vaccine Platforms against Henipaviruses | Journal of Virology
15 One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus
16 Make-up on the train: What's the problem?
17 Biofilm-associated bacterial amyloids dampen inflammation in the gut: oral treatment with curli fibres reduces the severity of hapten-induced colitis in mice
18 Strategies for transformational leadership
19 Letters: Junior doctors challenge Jeremy Hunt to a televised debate
20 University of York degree results